COVID Vaccines
COVID vaccines give a sense from its name and following renowned companies are involved to develop-
- Oxford Uni-AstraZenica
- Moderna
- Pfizer-BioNTech
- Gamaleya
Covishield
Covishield vaccine is developed by the Oxford-AstraZeneca and is being manufactured locally by the Serum Institute of India, the world’s largest vaccine manufacturer that produces more than 50 million doses a month. This vaccine is made from a weakened version of a common cold virus, an adenovirus from chimpanzees.
Note: Please come wearing comfortable clothes as COVID-19 vaccine is given intramuscularly at the upper arm and thus he had to take off his tight clothes as shown above clip.
Route of administration: Intramuscular (deltoid region)
Doses: two
Volume: 0.5 ml
Pain: Just like an ordinary ant bite
Next dose: Within 4 to 6 weeks but not more than 12 weeks
Note: COVID vaccine can’t cause COVID-19 infection since SARS-CoV-2 particles are not used to prepare this vaccine but the Covishield is made of a common cold virus, adenovirus from chimpanzees.
Vaccine type: Latest generation (recombinant vector vaccine)
Age group: 18 years and above age group are allowed to take this vaccine.
Who are not eligible to take Covishield vaccine?
- Age below 18 years
- Pregnant and breast-feeding women
- A person who has faced a severe side effect in any earlier vaccination.
- Active COVID-19 infection
- A person with acute severe illness or acute severe febrile illness
- COVID-19 patients who have taken monoclonal antibodies or convalescent plasma therapy.
- People having bleeding or coagulation disorders
Note: For the above points ( 4,5,6 and 7), the vaccine is only given in certain conditions.
Side effects of Covishield vaccine-
Common: affect up to 1 in 10 people
- A lump at the injection site
- Fever
- Vomiting
- Flu-like symptoms such as temperature, sore throat, running nose, cough and chills.
Uncommon side effects-
May affect up to 1 in 100 people
- Dizzy
- Decreased appetite
- Abdominal pain
- Enlarged lymph nodes
- Excessive sweating
- Itchy skin
- rash
Effective rate
62-90%
The Mechanism of a Vaccine
- In an ideal scenario, whenever a vaccine is first administered, it is phagocytized by an antigen-presenting cell.
- Recent research suggests that it is particularly important that the vaccine be taken up by a dendritic cell.
- This is because dendritic cells play a key role in activating T cells, which become helper T cells.
- From there, the activated Th cells go on to activate mature B-cells.
- These activated B-cells divide into two cell types, antibody-producing plasma cells and, most importantly, memory B cells.
Importance of Secondary Immune Response
During the secondary immune response, the body mounts a quicker, more robust attack on the pathogen.
Thus, the pathogen is cleared from the body before it has the chance to cause an infection.
Comparative Study of COVID-19 Vaccines
Comparative study of COVID-19 vaccines are given in a table –
Other Vaccines in Pipeline
The other COVID vaccines which are in different stages of trials in India to test safety and efficacy include-
- ZyCov-Di (developer-Ahmedabad-based Zydus-Cadila)
- In partnership with US-based Dynavax and Baylor College of Medicine, Hyderabad-based Biological E, the first Indian private vaccine company, is developing a vaccine.
- In partnership with Seattle-based HDT Biotech Company, HGCO19, India’s first mRNA vaccine developed by Pune-based Genova, uses bits of genetic code to induce an immune response. A nasal vaccine (Bharat BioTech)
- The Sputnik V vaccine (developers- Dr. Reddy’s Lab and Gamaleya National Centre in Russia)
- A second vaccine being developed by Serum Institute of India and American vaccine development company Novavax
Further Reading
- http://universe84a.com/vaccine-introduction-mechanism
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685956/
- https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained
- https://www.bbc.com/news/world-asia-india-55748124
- https://www.financialexpress.com/lifestyle/health/covid-19-vaccines-covishield-covaxin-side-effects-what-we-know-so-far/2176274/
